BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38105231)

  • 41. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
    Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the
    Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N
    Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis on CT in diagnosis of lymph node metastasis of thoracic esophageal cancer with minimum diameter greater than 1 cm].
    Wu HR; Liu CQ; Guo MF; Xu MQ; Mei XY
    Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):601-606. PubMed ID: 31422630
    [No Abstract]   [Full Text] [Related]  

  • 44. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
    Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
    BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.
    An YS; Sun JS; Park KJ; Hwang SC; Park KJ; Sheen SS; Lee S; Lee KB; Yoon JK
    Lung; 2008; 186(5):327-36. PubMed ID: 18670805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
    Moloney F; Ryan D; McCarthy L; McCarthy J; Burke L; Henry MT; Kennedy MP; Hinchion J; McSweeney S; Maher MM; O'Regan K
    Eur J Radiol; 2014 May; 83(5):843-7. PubMed ID: 24581594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
    Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
    Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer.
    Sioris T; Järvenpää R; Kuukasjärvi P; Helin H; Saarelainen S; Tarkka M
    Eur J Cardiothorac Surg; 2003 Mar; 23(3):403-8. PubMed ID: 12614814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review.
    Brea TP; Raviña AR; Villamor JMC; Gómez AG; de Alegría AM; Valdés L
    Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):9-16. PubMed ID: 29803524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
    Sung YM; Lee KS; Kim BT; Kim S; Kwon OJ; Choi JY; Yang SO
    AJR Am J Roentgenol; 2008 Jan; 190(1):246-52. PubMed ID: 18094319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T; Yu L; Li Y; Chen M
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):155-60. PubMed ID: 25800571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Hua J; Li L; Liu L; Liu Q; Liu Y; Chen X
    Nucl Med Commun; 2021 Nov; 42(11):1247-1253. PubMed ID: 34269750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
    Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
    Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
    Wang M; Liu L; Dai Q; Jin M; Huang G
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.
    Koksal D; Demirag F; Bayiz H; Ozmen O; Tatci E; Berktas B; Aydoğdu K; Yekeler E
    J Cardiothorac Surg; 2013 Apr; 8():63. PubMed ID: 23557204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy.
    Aaby C; Kristensen S; Nielsen SM
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):279-85. PubMed ID: 8587782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.